BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 35262978)

  • 41. Blood conservation strategies at United States hospitals during the COVID-19 pandemic: Findings from a multi-institutional analysis - International Society of Blood Transfusion survey.
    Jacobs JW; Karafin MS; Allen ES; Abels E; Park YA; Stephens LD; Ward DC; Woo JS; Gehrie EA; Booth GS; Adkins BD
    Transfusion; 2022 Nov; 62(11):2271-2281. PubMed ID: 36093583
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Survey based cross-sectional study to analyse the variation of practices at blood centres during COVID-19 pandemic in India.
    Basavarajegowda A; Bajpai M; Arora S; Maheshwari A; Dua S; Sahoo D
    Transfus Apher Sci; 2021 Jun; 60(3):103131. PubMed ID: 33865716
    [TBL] [Abstract][Full Text] [Related]  

  • 43. International Survey of Trials of Convalescent Plasma to Treat COVID-19 Infection.
    Murphy M; Estcourt L; Grant-Casey J; Dzik S
    Transfus Med Rev; 2020 Jul; 34(3):151-157. PubMed ID: 32703664
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regulatory consideration on preparation and clinical use of COVID-19 convalescent plasma.
    Yılmaz S; Ertuğrul Örüç N; Özcebe Oİ; Azap A; Çetin AT; Yenicesu İ; Öztürk A; Gündüz M; Tekin A
    Transfus Apher Sci; 2020 Oct; 59(5):102846. PubMed ID: 32593519
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factors driving availability of COVID-19 convalescent plasma: Insights from a demand, production, and supply model.
    Russell WA; Grebe E; Custer B
    Transfusion; 2021 May; 61(5):1370-1376. PubMed ID: 33590906
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Blood Banking and Transfusion Medicine Challenges During the COVID-19 Pandemic.
    Ngo A; Masel D; Cahill C; Blumberg N; Refaai MA
    Clin Lab Med; 2020 Dec; 40(4):587-601. PubMed ID: 33121624
    [TBL] [Abstract][Full Text] [Related]  

  • 47. COVID-19 convalescent plasma donors: Unique motivations in unique times?
    Crowder LA; Steele WR; Goodhue E; Lasky B; Young PP
    Transfusion; 2023 Apr; 63(4):703-710. PubMed ID: 36866426
    [TBL] [Abstract][Full Text] [Related]  

  • 48. COVID-19 vaccination: The impact on the selection criteria of the convalescent plasma donors.
    Bansal N; Raturi M; Bansal Y
    Transfus Clin Biol; 2021 Aug; 28(3):308-309. PubMed ID: 33971319
    [TBL] [Abstract][Full Text] [Related]  

  • 49. How we secured a COVID-19 convalescent plasma procurement scheme in Japan.
    Terada M; Kutsuna S; Togano T; Saito S; Kinoshita N; Shimanishi Y; Suzuki T; Miyazato Y; Inada M; Nakamoto T; Nomoto H; Ide S; Sato M; Maeda K; Matsunaga A; Satake M; Matsubayashi K; Tsuno H; Kojima M; Kuramistu M; Tezuka K; Ikebe E; Okuma K; Hamaguchi I; Shiratori K; Sato M; Kawakami Y; Inaba K; Igarashi S; Yamauchi R; Matsumura M; Ishimaru K; Zhang B; Kuge C; Ishihara M; Gouda M; Tanaka K; Ishizaka Y; Ohmagari N
    Transfusion; 2021 Jul; 61(7):1998-2007. PubMed ID: 34096059
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [COVID-19 - BLOOD GROUPS, ANTIBODIES AND CONVALESCENT PLASMA].
    Izak M; Yahalom V; Maor Y; Zimhoni O; Cohen D; Chen J; Shinar E
    Harefuah; 2021 Mar; 160(3):139-143. PubMed ID: 33749174
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transfusion medicine during COVID-19 outbreak in the hotspot of Spain.
    Hernández-Maraver D; Viejo A; Kerguelén AE; Jiménez-Yuste V
    Transfusion; 2020 Nov; 60(11):2762-2764. PubMed ID: 32815162
    [No Abstract]   [Full Text] [Related]  

  • 52. "Early transfusion of convalescent plasma in older patients with COVID-19 to prevent disease progression: A structured summary of a study protocol for a randomised controlled trial".
    Teofili L; Landolfi R; Cingolani A; Antinori A; Vecchiet J; Sanguinetti M; Gasbarrini A; Pasciuto T; Orlando N; Lamonica S
    Trials; 2020 Oct; 21(1):875. PubMed ID: 33092632
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Active surveillance of serious adverse events following transfusion of COVID-19 convalescent plasma.
    Swenson E; Wong LK; Jhaveri P; Weng Y; Kappagoda S; Pandey S; Pritchard A; Rogers A; Ruoss S; Subramanian A; Shan H; Hollenhorst M
    Transfusion; 2022 Jan; 62(1):28-36. PubMed ID: 34677830
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
    Chai KL; Valk SJ; Piechotta V; Kimber C; Monsef I; Doree C; Wood EM; Lamikanra AA; Roberts DJ; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2020 Oct; 10():CD013600. PubMed ID: 33044747
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Exploring the perspectives of members of international tuberculosis control and research networks on the impact of COVID-19 on tuberculosis services: a cross sectional survey.
    Nkereuwem O; Nkereuwem E; Fiogbe A; Usoroh EE; Sillah AK; Owolabi O; Tebruegge M; Badjan A; Kampmann B; Togun T
    BMC Health Serv Res; 2021 Aug; 21(1):798. PubMed ID: 34384439
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Motivators of and barriers to becoming a COVID-19 convalescent plasma donor: A survey study.
    Masser BM; Ferguson E; Thorpe R; Lawrence C; Davison TE; Hoad V; Gosbell IB
    Transfus Med; 2021 Jun; 31(3):176-185. PubMed ID: 33368777
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulatory challenges of convalescent plasma collection during the evolving stages of COVID-19 pandemic in the United States.
    Hassan S; West KA; Conry-Cantilena K; De Giorgi V
    Transfusion; 2022 Feb; 62(2):483-492. PubMed ID: 34778974
    [No Abstract]   [Full Text] [Related]  

  • 58. Blood supply management in times of SARS-CoV-2 pandemic - challenges, strategies adopted, and the lessons learned from the experience of a hospital-based blood centre.
    Pandey HC; Coshic P; C S C; Arcot PJ; Kumar K
    Vox Sang; 2021 May; 116(5):497-503. PubMed ID: 33103772
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
    Shen C; Wang Z; Zhao F; Yang Y; Li J; Yuan J; Wang F; Li D; Yang M; Xing L; Wei J; Xiao H; Yang Y; Qu J; Qing L; Chen L; Xu Z; Peng L; Li Y; Zheng H; Chen F; Huang K; Jiang Y; Liu D; Zhang Z; Liu Y; Liu L
    JAMA; 2020 Apr; 323(16):1582-1589. PubMed ID: 32219428
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adaptations of transfusion systems to the COVID-19 pandemic in British Columbia, Canada: Early experiences of a large tertiary care center and survey of provincial activities.
    McGinnis E; Guo RJ; Marcon KM; Berry B; Coupland R; Meneghetti V; Morrison D; Onell R; Steele L; Trudeau J; Wong M; Shih AW
    Transfusion; 2021 Apr; 61(4):1102-1111. PubMed ID: 33452826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.